Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease

Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease

CAMBRIDGE, Mass. and TOKYO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Today, the U.S. Food and Drug Adm...
read more